Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Boehringer Ingelheim
Colorcon
Moodys
Federal Trade Commission
Merck
Daiichi Sankyo
Citi

Generated: November 13, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Girentuximab

« Back to Dashboard

US Patents for Girentuximab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Girentuximab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Girentuximab ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Girentuximab ➤ Try a Free Trial Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Try a Free Trial
Girentuximab ➤ Try a Free Trial Antibodies with enhanced or suppressed effector function Zymeworks Inc. (Vancouver, British Columbia, CA) ➤ Try a Free Trial
Girentuximab ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Girentuximab

Drugname Country Document Number Estimated Expiration Related US Patent
Girentuximab Canada 2900764 2033-02-08 ➤ Try a Free Trial
Girentuximab European Patent Office 2954056 2033-02-08 ➤ Try a Free Trial
Girentuximab Hong Kong 1218930 2033-02-08 ➤ Try a Free Trial
Girentuximab Japan 2016509014 2033-02-08 ➤ Try a Free Trial
Girentuximab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
US Army
Cerilliant
Fuji
Julphar
Medtronic
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.